FDA Reissues Respirator EUAs

June 8, 2020

On Sunday, the Food and Drug Administration (FDA) reissued emergency use authorizations (EUAs) to specify which respirators are appropriate for decontamination for reuse. Based on the FDA’s increased understanding of the performance and design of these respirators, the FDA has decided that certain respirators should not be decontaminated for reuse by healthcare personnel.

The FDA has reissued the EUAs for:

The FDA also notes that according to Centers for Disease Control and Prevention’s recommendations, decontaminated respirators should only be used when new FDA-cleared N95 respirators, NIOSH-approved N95 respirators or other FDA authorized respirators are not available. The FDA will hold a webinar on this issue on Tuesday, June 9 at 11 a.m. CDT. Click here for more information (registration is not required).